n 2020, breast cancer in women overtook lung cancer as the most common disease diagnosed with cancer, with an estimated 2.3 million new patients. Among women, breast cancer is the second leading cause of cancer death after lung cancer, and with 1.2 million new cases each year, it is the most common malignant disease in women. Todays, medical procedures including surgery, radiation treatment, and chemotherapy are vitally helpful choices for treating breast cancer in routine, and chemotherapy stays the backbone of TNBC therapy. However, chemotherapeutic agent’s non-selective cytotoxicity has undesirable side effects. Drug resistance also creates a poor prognosis for the course of treatment. Even though many new treatments have been assessed, the impacts of treating TNBC remain poor, which stresses the necessity to investigate a novel technique for viable TNBC treatment. Cancer vaccines have attracted much attention as a pioneering way of cancer treatment. Therefore, it is crucial to look for anticancer medications that are more efficient and have fewer adverse effects.

Keywords